Topical Agents
Current approved therapies for plaque psoriasis include topical agents
like corticosteroids, vitamin D3, etc. applied to the skin.
Learn moreDiabetes study trial
Join our Diabetes Study Trial and contribute to empowering medical research. We are exploring groundbreaking techniques to manage and potentially cure diabetes. Your participation could help millions navigate this medical condition better and enjoy a healthier life.
Cards with icons
Systemic Therapies
Current approved therapies for plaque psoriasis include topical agents
like corticosteroids, vitamin D3, etc. applied to the skin.
Learn more
Phototherapy
Current approved therapies for plaque psoriasis include topical agents
like corticosteroids, vitamin D3, etc. applied to the skin.
Learn moreAre you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Pursuing progress against advanced prostate cancer
Joining a clinical trial is an important and personal decision. Your doctor may have mentioned the TALAPRO-3 study, or perhaps you found your way here by yourself. To qualify for this study, you may not have received certain anti-cancer treatments, such as:- platinum-based chemotherapy within the past 5 years
- a novel hormone therapy (NHT), such as enzalutamide, or abiraterone/prednisone, or apalutamide if taken for more than 3 months
- a PARP inhibitor (PARPi)
- androgen deprivation treatment for more than 3 months
Condition
metastatic Castration-Sensitive Prostate Cancer (mCSPC)Age
18+ yearsNumber of study visits
Upto 25Length of study
About 3 yearsAbout the Clinical Trials
Each facet of our study is designed with patient-centered care, scientific rigor, and innovation in mind. These six elements encapsulate our collaborative approach to advancing diabetes treatment. Each symbol illustrates a unique feature.
Patient Care
Individual patient well-being remains central. Personalized monitoring guarantees optimum health engagement.
Innovative Treatments
Exploring potentially revolutionary diabetes treatments through vaccination trials.
Knowledgeable Insights
Keeping participants informed and educated about the trial's progress and advancements.
Medication Trials
Testing novel medications for their effectiveness and safety in controlling diabetes.
Patient Care
Individual patient well-being remains central. Personalized monitoring guarantees optimum health engagement.
Innovative Treatments
Exploring potentially revolutionary diabetes treatments through vaccination trials.
Knowledgeable Insights
Keeping participants informed and educated about the trial's progress and advancements.
Medication Trials
Testing novel medications for their effectiveness and safety in controlling diabetes.
Scientific Evaluation
Ensuring rigorous, scientific assessments of each trial stage for reliable results.
Life Impact
Your participation helps shape a healthier future, impacting countless lives positively.
Timely ResearchCommitted to efficient research timelines, delivering results that contribute to rapid advancements in diabetes care.
Swift InnovationsPersistently pushing boundaries to unveil quick, novel solutions and treatments for diabetes.
Layered ApproachEmploying a comprehensive, multi-layered strategy to ensure thorough investigation and robust clinical trials.
Open CommunicationMaintaining a transparent dialogue with participants, ensuring they remain informed and reassured throughout the trial.
What to expect if you participate?
As a participant, expect rigorous health monitoring, access to potential innovative treatments, complete confidentiality, and consistent support throughout your journey.
3000+Participants
94%Clinical Trials Effectiveness
102,192Clinical Research
53,951Participants
94%Effectiveness
9,112Phase 1, 2, 3
Chat us
Our friendly team are here to help
info@trialx.com
Call us
Mon-Fri from 8am to 5pm
+1 (234) 567 8910
Visit us
Come say hello at our office HQ
260 Madison Avenue, 8th Floor, New York, NY - 10016, USA
Video title
Find a site near you
Contact Form
Add here a custom text for your form
Roberta Hills, PhD
Professor at the University of Washington
TrialX is developing novel, proprietary technologies that enable patients to find and learn about
clinical trials that match their health conditions and connect with the trial investigators effortlessly
using a unique web messaging platform.